Clinical Trial Update: SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC [Phase 2]

View source ↗

Summary

A Phase 2 trial in locally advanced rectal cancer is testing total neoadjuvant therapy with short-course radiotherapy followed by CAPOX and bevacizumab, with or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• PD-1 inhibitor

Snippet

Sponsor: Ruijin Hospital | Conditions: Rectal Cancer, Rectal Adenocarcinoma | Phase 2 | Status: RECRUITING